Why The First Quarter Could Be A 'High-Water Mark' For Regeneron
The first quarter could represent a "high-water mark" for Regeneron Pharmaceuticals, an analyst said Wednesday as REGN stock tumbled.
Edinburgh Worldwide Investment Trust plc is a closed-ended equity mutual fund launched and managed by Baillie Gifford & Co Ltd. The fund is co-managed by Baillie Gifford & Co. It invests in public equity markets across the globe. The fund seeks to invest in stocks of companies that are operating across diversified sectors. It primarily invests in growth stocks of small cap companies having market capitalization of less than $5 billion. The fund benchmarks the performance of its portfolio against the MSCI All Countries World Index. Edinburgh Worldwide Investment Trust plc was formed in 1998 and is domiciled in the United Kingdom.
| 160.2 | |
| 157 | |
| - | |
| 160.2 | |
| 156.216 | |
| 120.8-172.5 | |
| 606 M | |
| 378 M | |
| -74 310 000 | |
| -0.21 | |
| 0.776 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
The first quarter could represent a "high-water mark" for Regeneron Pharmaceuticals, an analyst said Wednesday as REGN stock tumbled.
The pharmaceutical company posts first-quarter revenue of $2.97 billion, up 17% from a year earlier.
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: